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MELATONIN AND ITS EFFECT ON LEARNING AND MEMORY 
Nechama Leah Bauman (Cahn) 
ABSTRACT 
Melatonin is a neurohormone produced by the pineal gland and secreted into the 
body in a circadian rhythm. Melatonin is known to be involved in many vital body 
functions, including sleep, reproduction, and immune response. Exogenous melatonin, 
sold as over the counter natural supplements in drugstores, is commonly taken by many 
people to help cure various ailments. Melatonin also plays a role in the hippocampus. 
This paper investigates the effects of melatonin on long-term potentiation in the 
hippocampus. Long-term potentiation, described as a long-lasting strengthening of 
synapses between nerve cells, is thought to be responsible for long-term memory 
retention. It is found that melatonin has a negative effect on long-term potentiation, 
inhibiting its magnitude. As long-term potentiation is related to some forms of learning 
and memory, melatonin inhibits learning and memory too. The practice of taking 
melatonin supplements causes one’s long-term potentiation to be inhibited to a greater 
degree than it would be under normal conditions and can significantly impact one’s 
learning and memory. In conclusion, although more studies need to be conducted, one 
should be wary and display caution before using melatonin supplements with any 
regularity.  
INTRODUCTION 
Melatonin, N-acetyl-5-methoxytryptamine, is a neurohormone synthesized mainly 
by the pineal gland. It is synthesized in a series of steps, starting with the conversion of 
tryptophan to serotonin. Serotonin is then converted to melatonin (Cardinali and Pevet 
1998) (Figure1). Melatonin is metabolized mainly in the liver. The major metabolite of 
melatonin is 6-sulfatoxymelatonin (Macchi and Bruce 2004). 
 
The suprachiasmatic nucleus controls melatonin levels in the body, which follows 
a circadian rhythm of high melatonin levels by night and low melatonin levels by day. 
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This pattern is controlled by an endogenous, independently run pacemaker in the 
suprachiasmatic nucleus. Light and darkness do not cause the circadian rhythm of 
melatonin but do have the ability to change its timing. Light inhibits melatonin 
production, while darkness stimulates it. Photic information from the retina is sent to the 
suprachiasmatic nucleous and from there to the pineal gland in the form of 
norepinephrine. When norepinephrine enters the pineal gland, melatonin is synthesized. 
When light hits the retina, the retinal photoreceptor cells become hyperpolarized, 
inhibiting norepinephrine release, thereby inhibiting melatonin production. When it is 
dark outside, the retinal photoreceptors do release norepinephrine, thereby stimulating 
melatonin production. (Brzezinski 1997). 
Melatonin is circulated to the rest of the body by passive diffusion into the 
bloodstream. It acts by binding to receptor sites. The receptors are part of the guanosine 
triphosphate-binding proteins and are G-protein coupled receptors (Brzezinski 1997). 
There are two subtypes of melatonin receptors: MT1 and MT2. Both subtypes are found 
in many areas of the body, including the cerebellum, retinal rods, ganglion cells, 
lymphocytes, and blood platelets. Since melatonin is very easily diffused, it has a 
systemic effect even without receptors at the basic cellular level, altering cytoskeletal and 
mitotic functions by binding to calmodulin, and acting as a free-radical scavenger 
(Macchi and Bruce 2004). 
Endogenous melatonin is involved in many of the processes of the body, 
including sleep, reproduction, and the immune system. Exogenous melatonin, sold as 
over-the-counter tablets in drugstores and health food stores, is used by many people to 
cure various disorders. 
Melatonin plays a major role in sleep. The circadian rhythm by which melatonin 
is synthesized is connected to sleep, and melatonin is also secreted in higher amounts at 
night, when people typically sleep (Brzezinski 1997). The effect of melatonin on sleep 
may also be related to changes in body temperature at night, with the nighttime decrease 
in body temperature, which is connected to the onset of sleep, increasing the evening 
secretion of endogenous melatonin. In fact, the highest point of melatonin production at 
night corresponds with the lowest point of body temperature (Macchi and Bruce 2004). 
Exogenous melatonin is often taken to correct sleeping problems. Flying over different 
time zones (jet lag) and working the night shift can disturb one’s circadian rhythm, and 
many people take melatonin supplements to try and cure this. Also, people with 
insomnia, who have trouble falling asleep or staying asleep, often take melatonin 
supplements (Brzezinski 1997). 
Melatonin also plays a role in the reproductive system. In animals that are 
seasonal breeders, the seasonal cycle, which is controlled by melatonin, regulates 
reproductive activity (Macchi and Bruce 2004). In humans, too, melatonin is involved in 
reproduction. Melatonin inhibits the reproductive process (Brzezinski 1997). 
Accordingly, melatonin supplements are sometimes taken by men and women to try and 
influence their reproductive systems. Additionally, there may be a relationship between 
endogenous melatonin levels and puberty (Macchi and Bruce 2004). 
Melatonin also plays a role in the immune system, increasing the immune 
response. This is thought to happen by high levels of melatonin stimulating T-helper cells 
and other parts of the immune system (Macchi and Bruce 2004). Melatonin is also a 
strong antioxidant. It is a free-radical scavenger, scavenging against toxic hydroxyl 
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radicals as well as other oxygen-centered radicals. This protects the macromolecules of 
the body, especially DNA (Brzezinski 1997). Melatonin is also thought to have oncostatic 
properties, slowing down the development of tumors, and is taken by some as a treatment 
for cancer (Macchi and Bruce 2004). 
Melatonin may also have an influence on the cardiovascular system. It may also 
have a connection to some psychiatric and neurological disorders (Macchi and Bruce 
2004). Some people take melatonin to prevent or to reduce the effects of coronary 
disease, Alzheimer’s disease, and Parkinson’s disease (El-Sherif et al. 2002). 
Melatonin is also thought to play a role in the processes of the brain. Melatonin 
receptors are present in the hippocampus, indicating that melatonin plays some role in 
that area (Wang et al. 2005). This research paper will look at the role of melatonin in the 
hippocampus and, specifically, at its effect on the process of long-term potentiation. It 
will also focus on the question of whether taking melatonin supplements, which inundate 
one’s body with greater levels of melatonin than are naturally synthesized, has a harmful 
effect on the long-term potentiation in the hippocampus.  
METHODS 
The information in this paper was obtained by critical analysis of scientific 
research articles. The articles used have to do with studies conducted on the topics of 
melatonin, long-term potentiation, and the connection between the two. The articles were 
found in the Touro College library databases. ScienceDirect was the database most 
frequently used.  
DISCUSSION 
The hippocampus is an essential part of the brain, located in the medial temporal 
lobe of the brain. The hippocampus is made up of several structures: the hippocampus 
proper, the dentate gyrus, and the subiculum. There are three main excitatory pathways in 
the hippocampus: the perforant pathway, the mossy fiber pathway, and the Schaeffer 
collaterals. The hippocampus is part of the limbic system and is involved in the formation 
of long-term memory (Rison and Stanton 1995). 
Learning and memory are stored in the brain as changes in the synapses between 
neurons (Medina and Izquierdo 1995). If two cells are active at the same time, the 
synapse between these cells is strengthened (Bliss and Collingridge 1993). In 1973, long-
term potentiation (LTP), a method in which learning and memory are stored in the 
hippocampus, was discovered by Tim Bliss and Terje Lomo. They found that short bursts 
of high-frequency stimulation to excitatory pathways in the hippocampus caused an 
increase in synaptic excitability that was long lasting, lasting even months long (Rison 
and Stanton 1995). Later on, it was discovered that LTP also causes a change in the ionic 
current, causing the ionic current to be different than that in regular synaptic transmission 
(Morris 2003).  
Long-term potentiation is induced by a specific mechanism. First, a high-
frequency tetanus is given to the neurons. This causes the postsynaptic membrane to 
become strongly depolarized by AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole 
proprionic acid) receptors located on the dendritic spine. The depolarization removes the 
magnesium (Mg) barrier of the NMDA (N-methyl-D-aspartate) receptors, also located on 
the dendritic spine. This allows sodium (Na), potassium (K), and calcium (Ca) to flow 
through (See Figure 2). Calcium concentrations rise in the dendritic spine, triggering 
calcium dependent processes necessary in order for LTP to occur. The calcium dependent 
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processes cause changes in the synapse that increase synaptic strength, achieving long-
term potentiation (Rison and Stanton 1995). 
 
In order for the synapses to be strengthened in LTP, there must be correlated 
activity, meaning that the presynaptic and postsynaptic neurons must be active 
simultaneously. NMDA receptors make this happen by opening their channels only when 
stimulated by both neurons. Only after receiving glutamate from the presynaptic neuron 
as well as the removal of the magnesium block by depolarization of the postsynaptic 
neuron do NMDA receptors open their channels and enable the rest of the LTP pathway 
to occur (Tsien et al. 1996). 
Long-term potentiation is connected to memory and learning. Synaptic plasticity, 
meaning change in synaptic strength, is caused by LTP and seems to be the way in which 
learning and memory are stored in the brain. Studies show that synaptic weights changed 
after learning, showing that learning is connected to LTP. Also, when the mechanisms 
involved in synaptic plasticity were changed, the rate of learning was also changed. Even 
after the learning was completed, changing of the synaptic weights affected the 
experimental animals’ ability to remember what they learned. Interfering with LTP is 
seen to also interfere with learning and memory, showing that LTP is very involved with 
these tasks (Morris 2003).  
In order to experiment with long-term potentiation, it must be easily stimulated 
and measured. During experimentation, long-term potentiation is usually induced by 
giving a tetanus, a stimulus, to a hippocampal slice. The tetanus must be sufficiently 
strong, usually at least 100 Hz, in order to invoke LTP (Bliss and Collingridge 1993). 
LTP is measured by recording the field excitatory postsynaptic potential (fEPSP) in the 
hippocampal slice after the tetanus. Experimenting with changes in the strength of 
synaptic connection allows one to learn about what causes these changes and how it 
might be linked to learning and memory (Wang et al. 2005).  
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Many studies have been performed investigating the effect of melatonin in the 
hippocampus. Their results showed that melatonin affects LTP by changing the synaptic 
transmission between neurons (Wang et al. 2005).  
One such study, performed by Louisa M. Wang, proved that melatonin inhibits 
LTP in neurons. Wang proved this in an experiment using hippocampal slices of mice. 
First, LTP was induced with   high-frequency stimulation, and the results were recorded 
for 60 minutes. Melatonin was then applied to the hippocampal slices, and LTP was 
induced again. This time, the field excitatory postsynaptic potential (fEPSP) slopes were 
much lower, showing that the melatonin had reduced the magnitude of LTP (Wang et al. 




Yoshiyuki Takahashi also experimented with melatonin, investigating its role in 
LTP. Using hippocampal slices from rat brains, he tested the effect of melatonin on LTP 
in the CA1 region of the hippocampus. Compared to the control group, melatonin 
considerably lowered the expression of LTP (Takahashi and Okada 2011).  
These two studies illustrate that one role of melatonin in the hippocampus is to 
inhibit LTP. In both experiments, after the addition of melatonin, LTP was significantly 
lower than the control groups.  
After learning that melatonin inhibits long-term potentiation, the next step is to 
figure out how it is accomplished. What mechanism is in place that connects melatonin 
an indoleamine neurohormone, to LTP, a process of memory? 
Of the two known melatonin receptor subtypes, MT1 and MT2, the inhibitory 
effect of melatonin seems to occur through the MT2 receptor. Wang illustrates this with 
his receptor-specific experiments. Luzindole, a nonselective melatonin receptor 
antagonist, blocked melatonin’s inhibitory effect on LTP. This was expected, for if 
melatonin is not able to bind to receptors then it cannot act. However, 4-P-PDOT, a MT2-
selective antagonist, also blocked melatonin’s inhibitory effect on LTP. Here, melatonin 
was able to attach only to the MT1 receptors and not the MT2 receptors, and it did not act 
on LTP. This shows that melatonin inhibits LTP through the MT2 receptors (Wang et al. 
2005).  
Wang additionally proved this idea through experiments on genetically modified 
mice. In mice deficient in both MT1 and MT2 receptors, melatonin exhibited no 
inhibitory effects because it had no receptors on which to attach. In mice deficient only in 
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MT2 receptors, again melatonin had no effect. However, in mice deficient only in MT1 
receptors, melatonin did inhibit LTP. Thus, it is the MT2 receptors which allow 
melatonin’s effect on LTP, and as long as the MT2 receptors are present, melatonin 
works its effect in the hippocampus (Wang et al. 2005).  
Dawn R. Collins suggested that perhaps the mechanism for melatonin’s inhibition 
of LTP is based on N-methyl-D-aspartate (NMDA) receptors. Melatonin is similar in 
structure to some NMDA receptor antagonists, and if melatonin blocks NMDA receptors, 
then LTP would be inhibited. However, in experimentation, melatonin was found to have 
no effect on NMDA receptor-mediated responses, thus not inhibiting LTP through a 
mechanism involving the blockade on NMDA receptors (Collins and Davies 1997).  
Wang hypothesized that the mechanism for LTP inhibition by melatonin involves 
the inhibition of the Adenylyl cyclase- protein kinase A pathway (AC- PKA pathway), 
which is involved in LTP. As MT2 receptors are negatively coupled to AC and PKA 
activity, and melatonin is mediated through MT2 receptors, it seems possible that 
melatonin’s mechanism of action is through the AC-PKA pathway. If it is true that 
melatonin inhibits LTP through the inhibition of the AC-PKA pathway, then PKA 
inhibitors should likewise inhibit LTP the same way that melatonin does. Therefore, 
Wang tested H89, a PKA inhibitor, in its ability to inhibit the induction of LTP. H89 did 
inhibit LTP, to the same extent as melatonin did. This experiment, as well as further 
experiments testing the hypothesis, shows that melatonin works to block LTP induction 
by a mechanism involving the inhibition of the AC-PKA pathway (Wang et al. 2005).  
However, the mechanism for melatonin action in the hippocampus is not 
straightforward. Takahashi demonstrated that melatonin blocked the induction of LTP 
with a mechanism involving the inhibition of the nitric oxide (NO) signaling pathway. 
The nitric oxide cascade is a precursor to LTP. In order for LTP to occur, a high-
frequency stimulation must be given, leading to postsynaptic calcium concentrations. The 
calcium activates the production of nitric oxide. Nitric oxide leads to cGMP synthesis, 
protein kinase G activation, and finally to LTP induction. Thus, by melatonin inhibiting 
the nitric oxide signaling pathway, it leads to inhibition of LTP. One method Takahashi 
used to prove this experimentally was the application of L-NAME, a nitric oxide synthase 
inhibitor, to hippocampal slices. L-NAME inhibited LTP, just as melatonin did. Because 
melatonin inhibits LTP by inhibiting nitric oxide pathway, both melatonin and nitric 
oxide inhibitor should have the same end result of LTP inhibition. Each of them should 
achieve the same LTP inhibition, and putting both melatonin and nitric oxide inhibitor 
should not increase the level of LTP inhibition, because they both act on the same nitric 
oxide pathway. Takahashi tried this and got the hypothesized results, supporting the idea 
that melatonin inhibits LTP by inhibiting the nitric oxide cascade (Takahashi and Okada 
2011).  
Both the AC-PKA pathway and the nitric oxide pathway are mechanisms 
involved in melatonin inhibition of LTP in the hippocampus. There is thought to be an 
interaction between the two pathways (Takahashi and Okada 2011).  
As previously mentioned, long-term potentiation is involved in learning and 
memory. Everything discussed above about melatonin inhibiting LTP means that in some 
way, melatonin is inhibiting the brain’s ability to learn and store memory. With the 
endogenous melatonin produced naturally by the pineal gland, this inhibition is part of 
the body’s natural cycle. Just as melatonin is produced in a circadian rhythm, LTP is also 
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found to have a circadian rhythm. The magnitude of LTP in the hippocampus is larger 
during the day, when less melatonin is produced, and smaller in the night when melatonin 
production rises (Takahashi and Okada 2011). Studies conducted by Arun V. Raghavan 
confirm the change in LTP strength between day and night. Raghavan found that 
hippocampal slices taken from hamsters during daytime showed a much greater measure 
of LTP than in those taken from hamsters during the nighttime (Raghavan et al. 1999). 
Since LTP is involved with learning and memory, learning and memory also must show a 
circadian rhythm (Takahashi and Okada 2011).  
However, melatonin’s effect on LTP is concentration dependent. Higher 
concentrations of melatonin have been found to inhibit LTP to a greater extent than lower 
concentrations (Wang, et. al. 2005). This information is crucial when considering the 
effects of melatonin on learning and memory. The circadian rhythm of learning and 
memory, from the circadian rhythm of endogenous melatonin, is a normal part of our 
body functioning. However, the intake of exogenous melatonin supplements places 
higher doses of melatonin into our body then usual, which causes LTP to be inhibited to a 
greater degree then normal. It is possible that melatonin supplements can seriously inhibit 
LTP, negatively affecting one’s learning and memory to a significant degree. In fact, Xiu-
Jing Cao conducted studies on the long-term effect of low dose melatonin on long-term 
potentiation and its subsequent effects on learning and memory, focusing especially on 
spatial learning. Spatial learning is awareness about one’s surroundings and orientation in 
space. The study concluded that exogenous melatonin causes lasting harm to learning and 
memory (Cao et al. 2009).  
Cao experimented with rats. The rats were given melatonin for sixty days and 
were then tested to evaluate their ability for spatial learning and to measure their LTP 
levels. Spatial learning was tested using the Morris Water Maze test. In this test, the rats 
were placed in a pool of water. In order to escape the water, the rats had to find the 
platform hidden in the water. The rats’ spatial memory was tested by their ability to 
remember the platform’s position by using spatial cues. When using more spatial 
memory, the platform was found faster. In this experiment, both the control group and the 
melatonin group showed decreasing reaction time, finding the platform faster as the 
experiment progressed. However, the group with melatonin still took significantly longer 
in the maze than the group without melatonin. The exogenous melatonin weakened the 
rats’ spatial memory (Cao et al. 2009).  
The long-term potentiation of the rats’ hippocampi was then tested. As expected, 
the results showed that LTP had been inhibited in the melatonin-exposed rats, when 
compared to the control group. The fEPSP slope of the melatonin group was significantly 
less than that of the control group (Cao et al. 2009) (See Figure 3 above). 
This study shows that melatonin inhibits LTP, impairing spatial memory and 
learning, because this type of learning and memory is related to LTP (Cao et al. 2009).  
The melatonin in this study was given to the rats in low doses of 3 mg/kg for a 
relatively long period of 60 days. This is the same way that many people take melatonin 
supplements. Countless people take a low dose melatonin pill daily. However, the Cao 
study shows proof that this daily melatonin supplement can be harmful. It actually lowers 
LTP and affects spatial learning and memory. As Cao concluded, “melatonin should not 
be used as… [a] dietary supplement,” for it harms learning and memory (Cao et al. 2009).  
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An experiment conducted by Ruben Soto-Moyano found that melatonin’s 
inhibition of long-term potentiation damages visuo-spatial memory. Visuo-spatial skills 
involve one’s visual perception of spatial relationships. Soto-Moyano tested visuo-spatial 
memory using the 8-arm radial Olton maze. This maze consists of a central point with 
eight arms extending out from it. The rat is required to run up and down the arms to find 
the food placed at the end of one of the arms. This maze tests visuo-spatial working 
memory (Soto-Moyano et al. 2005). The experiment included rats treated with melatonin 
and a control group of rats not treated with melatonin. In the maze, the rats treated with 
melatonin made more errors and took more time to solve the task than the control group. 
This shows that melatonin weakened the visuo-spatial working memory of rats. The 
control group performed better as time went on, meaning that they used long-term 
memory to help remember the maze. The rats with melatonin had their long-term 
memory damaged by the melatonin, proven by the higher number of errors even over 
many days of testing (Soto-Moyano et al. 2005).  
This experiment by Soto-Moyano demonstrates that the LTP inhibition caused by 
exogenous melatonin harms visuo-spatial memory. Taking melatonin supplements may 
inhibit one’s visuo-spatial learning and memory. Tasks that involve visuo-spatial 
processing, such as estimating distance and depth, may be damaged by melatonin 
supplements.  
CONCLUSION 
As seen in the above studies, melatonin inhibits long-term potentiation, 
consequently inhibiting learning and memory, especially spatial memory and visuo-
spatial skills. With the ingestion of melatonin supplements, melatonin enters the body in 
amounts greater than usual. These higher levels of melatonin cause a greater inhibition of 
LTP and significant inhibition of learning and memory.  
 Additional studies must be conducted to learn more about melatonin’s effect on 
the hippocampus. None of the findings discussed above are fully conclusive, and more 
research is needed on order to clarify the guidelines for the safe use of melatonin. 
However, it can be concluded from the studies discussed above that there is a definite 
relationship between melatonin, LTP inhibition, reduced spatial memory, and learning. 
Melatonin is sold over the counter in the form of natural supplements in 
drugstores throughout the United States. These melatonin pills are often intended to help 
with various ailments, including jet lag, insomnia, and reproduction. However, people 
should be advised that taking melatonin pills long term or on a regular basis could 
possibly have negative side effects, impairing one’s learning and memory capability. 
Melatonin supplements, although unregulated and promoted as natural, should not be 
taken unless medically advised, and even then, only with extreme caution.  
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